Literature DB >> 2835043

Tissue distribution of an endogenous ligand to the Na, K ATPase molecule.

A L Rauch1, V M Buckalew.   

Abstract

A variety of evidence indicates the presence of a circulating ligand to the Na, K ATPase molecule that is involved in the regulation of extracellular sodium metabolism. To examine the potential role of endogenous ligands to the Na, K ATPase molecule in the regulation of intracellular sodium metabolism, the tissue distribution of digitalis-like activity was quantitated in several brain regions and peripheral organs. The digitalis-like activity of desalted and delipidated extracts of tissue was widely distributed and produced a displacement of tritiated ouabain that was parallel to the displacement produced by cold ouabain. These results suggest that tissue contains an endogenous ligand to the Na, K ATPase molecule and that this ligand may regulate intracellular sodium metabolism in an autocoid-like manner.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835043     DOI: 10.1016/s0006-291x(88)80111-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function.

Authors:  D Lichtstein; H Rosen
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Differential effects of Na+, K(+)-ATPase inhibition by ouabain on acid secretory responses to histamine and bethanechol in the mouse isolated stomach.

Authors:  S Horie; S Yano; K Watanabe
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  "The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?

Authors:  Heidrun Weidemann
Journal:  J Carcinog       Date:  2012-02-17

4.  Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS.

Authors:  Mengfei Han; Geliang Yang; Qing Lin; Yanlong Yang; Huiqing Zhang; Yonghua Su
Journal:  Front Oncol       Date:  2020-01-23       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.